This site is intended for health professionals only

Editor’s pick

FDA gives new Zyprexa “green light”
FDA gives new Zyprexa “green light”
FDA grants provisional approval for copycat esomeprazole magnesium
FDA grants provisional approval for copycat esomeprazole magnesium
EMEA will review Vidaza for myelodysplastic syndromes
EMEA will review Vidaza for myelodysplastic syndromes
More deaths “linked” to superbug
More deaths “linked” to superbug
Results announced for phase III trial of Gamunex in CIDP patients
Results announced for phase III trial of Gamunex in CIDP patients
GE Healthcare to acquire Whatman Plc
GE Healthcare to acquire Whatman Plc
UK leading research in medicines for breathing disorders
UK leading research in medicines for breathing disorders
Plavix sales buoy Bristol-Myers
Plavix sales buoy Bristol-Myers
Charity to spend £4bn on research
Charity to spend £4bn on research
Yoghurt plan to tackle superbugs
Yoghurt plan to tackle superbugs
FDA will review Cimzia for rheumatoid arthritis treatment
FDA will review Cimzia for rheumatoid arthritis treatment
Trust denies MRSA blood move link
Trust denies MRSA blood move link
1 … 219 220 221 222 223 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x